The latest announcement is out from Haleon PLC ( (GB:HLN) ).

Haleon PLC HLN shares rallied 1.13% to £3.59 Wednesday, on what proved to be an all-around favorable trading session for the ...

On August 15, 2025, Haleon PLC announced the purchase and cancellation of 1,399,293 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This ...

Haleon plc (NYSE:HLN) is one of the best NYSE stocks to buy under $20. In a report released on August 4, Morgan Stanley ...

It looks like Haleon plc ( LON:HLN ) is about to go ex-dividend in the next three days. The ex-dividend date is ...

Haleon PLC (NYSE:HLN) claims it isn’t primarily liable in ranitidine (Zantac) lawsuits. Unknown whether Haleon will pay anything: it fell 12.5% over two days when an analyst raised the issue in ...

Haleon PLC closed 15.18% short of its 52-week high of £4.20, which the company reached on May 30th.

Haleon PLC is a consumer healthcare company and provides personal healthcare products. The group conducts business internationally across five consumer healthcare categories: Oral Health, Pain ...

Haleon plc has seen slight growth since its separation from GSK, with a 0.49% increase in YoY gains. See why I recommend a hold rating for HLN stock.

David Hayes has given his Buy rating due to a combination of factors that distinguish Haleon PLC from its competitors. The adjustments needed for Haleon’s second-quarter performance are ...

Haleon PLC ( (GB:HLN) ) has shared an update. Haleon PLC has announced a regulatory notification concerning transactions by Persons Discharging Managerial Responsibilities (PDMRs) within the company.

Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses.